Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods for enhanced protein production

a protein and cell culture technology, applied in the field of mammalian cell culture, can solve the problems of limited cell density, poor quality, and product toxic to cell growth, and achieve the effects of high cell density, shortening the time period, and increasing the quantity of protein

Inactive Publication Date: 2014-10-09
ER SQUIBB & SONS INC
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach enables the production of higher quantities of high-quality protein in a shorter time frame, overcoming the limitations of traditional methods by achieving cell densities and protein yields not previously possible, enhancing the efficiency and effectiveness of protein production in mammalian cell cultures.

Problems solved by technology

Specifically, the maximum cell density achieved using known cell cultures techniques is generally thought to be limited by the presence of particular levels of waste products (e.g., lactate, ammonium, etc.), since it is known that such waste products can be toxic to cell growth when they accumulate to critical concentrations (see, for example, Schumpp, B. et al., J.
This increases the freshness, stability and quality of the protein, in contrast to protein obtained from both perfusion and fed-batch cultures subjected to longer periods of culture, which is thus more susceptible to degradation and generally of poorer quality.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for enhanced protein production
  • Methods for enhanced protein production
  • Methods for enhanced protein production

Examples

Experimental program
Comparison scheme
Effect test

example 1

Super Density Fed-Batch Cell Culture Process

A. Experimental Methods

[0095]Recombinant CHO cells (i.e., antibody producing CHOK1SV cells) were expanded in cell culture flasks before inoculating the Wave perfusion bioreactor. The perfusion bioreactor was operated with the same basal medium that is used in cell expansion process. The perfusion rate was adjusted to maintain a healthy culture with high cell viabilities. In certain experiments, cells were concentrated to a higher cell density, as appropriate, by adjusting the medium in and out flow rates. Once the viable cell density reached greater than 50×106 cells / mL, fed-batch production process was started. The culture was fed by a combination of bolus and continuous feeding modes, so as to control the osmolality and glucose level. The cell culture was then harvested when cell viability decreased to approximately 60-10%.

experiment 1

B. Experiment 1

[0096]Cells were inoculated in a BIOSTAT Cultibag (Sartorius) at approximately 0.84×106 cells / mL. The specific perfusion rate (SPR) ranged from 0.25 to 0.03×10−6 mL cell−1 day−1. Cells were concentrated about 2.6 fold when viable cell density reached 12.6×106 cells / mL. After concentration, cells were grown up to 108.8×106 cells / mL. Once the cells reached 108.8×106 cells / mL, perfusion was stopped and the fed-batch process was started immediately. During the fed-batch process, one or two bolus feeds at 3 to 10% (i.e., percentage of feed to post feed volume) were performed every day to maintain cell viability. Glucose was also supplemented by bolus feed to maintain a sufficient level. Cell density reached 124.66×106 cells / mL with 98% viability the second day after fed-batch process started. The total feed percentage was about 40%. As shown in the growth and production profile depicted in FIG. 3, a final productivity of 8.8 g / L from fed-batch process was achieved after 6 ...

experiment 3

D. Experiment 3

[0100]Cells were inoculated in the WAVE BIOREACTOR® (GE Healthcare, Fairfield, Conn.) at approximately 1.20×106 cells / mL. The rate of specific perfusion (SPR) ranged from 0.07 to 0.03 (e.g., 0.05)×10−6 mL cell−1 day−1 and varied at different time points. As shown in FIG. 5, cells were partially transferred on day 13 and day 18 to two separate 5 liter stir tank bioreactors at a cell density of approximately 50×106 cells / mL. Antifoam was also added to overcome foaming in the bioreactors. As shown in the growth and production profile depicted in FIG. 5, a final productivity of 6.3 g / L at about 40% viability was achieved from the fed-batch cells transferred on day 13 (i.e., 2391AB) (see FIG. 6). A final productivity of 7.1 g / L at about 38% viability was achieved from the fed-batch cells transferred on day 18 (i.e., 2391BB) (see FIG. 6).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a method of increasing protein production in a cell culture by growing cells that produce the protein (e.g., the growth phase) in a perfusion cell culture to a high cell density (i.e., at least above about 40×106 cells / mL) and then switching to a protein production phase, wherein the cells are cultured in a fed-batch cell culture. The present invention further provides a method for clarifying a protein from a cell culture by adjusting the pH of the cell culture to below neutral pH (i.e., below a pH of 7) and settling the cell culture, such that the cell culture separates to form a supernatant layer and a cell-bed layer, wherein the protein is in the supernatant layer.

Description

CROSS REFERENCE TO RELATED APPLICATION[0001]This application is a divisional of U.S. application Ser. No. 13 / 510,372, filed Jun. 14, 2012, which claims the benefit of International Application No. PCT / U.S. 2010 / 056924, filed on Nov. 17, 2010, which claims the benefit of 61 / 261,886, filed Nov. 17, 2009, the entire contents of all of which are herein incorporated by reference.BACKGROUND OF THE INVENTION[0002]Animal cell culture, particularly mammalian cell culture, is commonly used for the expression of recombinantly produced proteins for therapeutic, prophylactic and diagnostic purposes. Although mammalian cell culture methods are preferred over microbial expression systems (e.g., bacterial or yeast expression systems), because they are better suited to express high molecular weight proteins and proteins having complex steric structures, protein expression levels from mammalian cell culture-based systems are generally considerably lower than those from microbial expression systems. W...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K1/30C07K16/00
CPCC07K16/00C07K2317/14C07K1/30C12P21/00C12P21/02C12N1/02
Inventor ARUNAKUMARI, ALAHARIDAI, XIAO-PINGGARCIA, JAVIERMARTEL, RICHARD P.
Owner ER SQUIBB & SONS INC
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More